Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer’s Disease
Artur Shvetcov(The University of Sydney), Caitlin A. Finney(Westmead Institute for Medical Research), Daniel Catchpoole(Children's Hospital at Westmead), Timothy A. Couttas(The University of Sydney), Shantel L. Duffy, Shannon Thomson(The University of Sydney), Ann‐Na Cho(The University of Sydney), Shea J. Andrews(University of California, San Francisco), Heather Wilkins(University of Kansas Medical Center), Carol Dobson‐Stone(Neuroscience Research Australia), Russell H. Swerdlow(University of Kansas), Natasha M. Rogers(The University of Sydney), Eleanor Drummond(The University of Sydney), David A. Brown(UNSW Sydney), Jessica Spathos(Westmead Institute for Medical Research), Jasmeen Kaur Issar(The University of Sydney), Simranpreet Kaur(Royal Children's Hospital), Wendy Gold(Children's Medical Research Institute), Finula I. Isik(The University of Sydney), Fabien Delerue(The University of Texas MD Anderson Cancer Center)
Cited by 9
Related Papers
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
|Nature Reviews Drug Discovery|2020|982
Mitochondrial function as a therapeutic target in heart failure
|Nature Reviews Cardiology|2016|786
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids
|Nature Genetics|2011|578
Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety
|Molecular Psychiatry|2009|528
Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids
|Nature Communications|2021|365